CA Patent

CA2443466A1 — An aqueous pharmaceutical preparation of cilostazol for parenteral use

Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2002-12-27 · 23y expired

What this patent protects

An aqueous preparation for injections which contains cilostazol or a pharmacologically acceptable salt thereof as the active ingredient and furth er contains a cyclodextrin. Due to the cyclodextrin, the solubility of the cilostazol or salt in the water is heightened. As a result,…

USPTO Abstract

An aqueous preparation for injections which contains cilostazol or a pharmacologically acceptable salt thereof as the active ingredient and furth er contains a cyclodextrin. Due to the cyclodextrin, the solubility of the cilostazol or salt in the water is heightened. As a result, the aqueous preparation in the solution state has improved long-term stability.

Drugs covered by this patent

Patent Metadata

Patent number
CA2443466A1
Jurisdiction
CA
Classification
—
Expires
2002-12-27
Drug substance claim
No
Drug product claim
No
Assignee
Otsuka Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.